Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Withdrawn × Electroporation × Clear all

Phase

Phase NA 5 Phase 1/2 1

Status

Completed 6 Unknown 3 Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 21 pembrolizumab 19 Nivolumab 14 Fluorouracil 14 Cisplatin 14 Leucovorin 12 Capecitabine 12 Bevacizumab 12 Oxaliplatin 11 Carboplatin 11 Lenalidomide 10 Dexamethasone 10 fludarabine 9 avelumab 9 Taxes 9 Rituximab 9 Radiotherapy 9 Gemcitabine 9 Radiosurgery 8 Azacitidine 8 venetoclax 7 fludarabine phosphate 7 Irinotecan 7 Ipilimumab 7 Docetaxel 7 ALT-803 7 Omacor 6 Melphalan 6 Interleukin-2 6 Etoposide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01764009 2015-09-11

AIMM

Valerio Therapeutics

Phase 1/2 Withdrawn

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡